Skip to main content
Erschienen in: Rheumatology International 10/2010

01.08.2010 | Original Article

Male gender results in more severe lupus nephritis

verfasst von: Jozélio Freire de Carvalho, Ana Patrícia do Nascimento, Leonardo A. Testagrossa, Rui Toledo Barros, Eloísa Bonfá

Erschienen in: Rheumatology International | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Gender may produce different characteristics in the manifestation of systemic lupus erythematosus (SLE). The present study investigated the influence of gender on clinical, laboratory, autoantibodies and histopathological classes of lupus nephritis (LN). As much as 81 patients diagnosed with SLE (ACR criteria) and active nephritis, who underwent renal biopsy between 1999 and 2004, and who had frozen serum samples and clinical data available from the time of biopsy, were selected for this study. The presence of anti-P and antichromatin antibodies was measured using ELISA, and anti-dsDNA was measured using indirect immunofluorescence. All of the renal biopsies were reviewed in a blinded manner by the same expert renal pathologist. The charts were extensively reviewed for demographic and renal features obtained at the time of the biopsy. Of the 81 patients (13.6%), 11 were male SLE patients. Both male and female lupus patients were of similar age and race, and had similar durations of lupus and renal disease. The female patients had more cutaneous (95.7 vs. 45.5%, P = 0.0001) and haematological (52.9 vs. 18.2%, P = 0.04) involvements than the male SLE patients. In addition, the articular data, central nervous system analyses, serositis findings and SLEDAI scores were similar in both experimental groups. Positivity for anti-dsDNA, anti-ribosomal P and antichromatin did not differ between the two groups, and both groups showed similarly low C3 or C4 serum levels. Our analysis indicated that no histopathological class of LN was predominant in both males and females. Interestingly, the serum creatinine levels were higher in the male SLE patients compared to the female SLE group (3.16 ± 2.49 vs. 1.99 ± 1.54 mg/dL, P = 0.03), with an increased frequency of high creatinine (81.8 vs. 47.1%, P = 0.04) as well as renal activity index (7.6 ± 3.5 vs. 4.8 ± 3.5, P = 0.02). In addition, whilst the mean levels of proteinuria, cylindruria and serum albumin were markedly altered, they were comparable between both lupus men and women. Moreover, the frequencies of dialysis, renal transplantation and death were similar between the two groups. These data suggest that male patients had a more severe LN compared to women diagnosed with this renal abnormality.
Literatur
1.
Zurück zum Zitat Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6:366–372CrossRefPubMed Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6:366–372CrossRefPubMed
2.
Zurück zum Zitat Martins L, Rocha G, Rodrigues A et al (2002) Lupus nephritis: a retrospective review of 78 cases from a single center. Clin Nephrol 57:114–119PubMed Martins L, Rocha G, Rodrigues A et al (2002) Lupus nephritis: a retrospective review of 78 cases from a single center. Clin Nephrol 57:114–119PubMed
3.
Zurück zum Zitat Arbuckle MR, James JA, Dennis GJ et al (2003) Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 12:99–106CrossRefPubMed Arbuckle MR, James JA, Dennis GJ et al (2003) Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 12:99–106CrossRefPubMed
4.
Zurück zum Zitat Wang F, Wang CL, Tan CT, Manivasagar M (1997) Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 6:248–253CrossRefPubMed Wang F, Wang CL, Tan CT, Manivasagar M (1997) Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 6:248–253CrossRefPubMed
5.
Zurück zum Zitat Soni SS, Gowrishankar S, Adikey GK, Raman A (2008) Sex-based differences in lupus nephritis: a study of 235 Indian patients. J Nephrol 21:570–575PubMed Soni SS, Gowrishankar S, Adikey GK, Raman A (2008) Sex-based differences in lupus nephritis: a study of 235 Indian patients. J Nephrol 21:570–575PubMed
6.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:17CrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:17CrossRef
7.
Zurück zum Zitat Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530CrossRefPubMed Weening JJ, D’Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530CrossRefPubMed
8.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed
9.
Zurück zum Zitat Aarden LA, de Groot ER, Feltkamp TE (1975) Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 254:505–515CrossRefPubMed Aarden LA, de Groot ER, Feltkamp TE (1975) Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 254:505–515CrossRefPubMed
10.
Zurück zum Zitat Carvalho JF, Viana VS, Borba EF et al (2008) High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis. Clin Rheumatol 27:1417–1421CrossRefPubMed Carvalho JF, Viana VS, Borba EF et al (2008) High-titer antichromatin antibody is associated with proliferative class IV of lupus nephritis. Clin Rheumatol 27:1417–1421CrossRefPubMed
11.
Zurück zum Zitat Magsaam J, Gharavi AE, Parnassa AP, Weissbach H, Brot N, Elkon KB (1989) Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients’ mononuclear cells. Clin Exp Immunol 76:165–171PubMed Magsaam J, Gharavi AE, Parnassa AP, Weissbach H, Brot N, Elkon KB (1989) Quantification of lupus anti-ribosome P antibodies using a recombinant P2 fusion protein and determination of the predicted amino acid sequence of the autoantigen in patients’ mononuclear cells. Clin Exp Immunol 76:165–171PubMed
12.
Zurück zum Zitat Bonfa E, Golombek SJ, Kaufman LD et al (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271PubMed Bonfa E, Golombek SJ, Kaufman LD et al (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271PubMed
13.
14.
Zurück zum Zitat Mannik M, Merrill CE, Stamps LD, Wener MH (2003) Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495–1504PubMed Mannik M, Merrill CE, Stamps LD, Wener MH (2003) Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495–1504PubMed
15.
Zurück zum Zitat Foster MH, Cizman B, Madaio MP (1993) Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest 69:494–507PubMed Foster MH, Cizman B, Madaio MP (1993) Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest 69:494–507PubMed
16.
Zurück zum Zitat Cervera R, Viñas O, Ramos-Casals M et al (2003) Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 62:431–434CrossRefPubMed Cervera R, Viñas O, Ramos-Casals M et al (2003) Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 62:431–434CrossRefPubMed
17.
Zurück zum Zitat do Nascimento AP, Viana VST, Testagrossa LA et al (2006) Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 54:1568–1572CrossRefPubMed do Nascimento AP, Viana VST, Testagrossa LA et al (2006) Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 54:1568–1572CrossRefPubMed
18.
Zurück zum Zitat Renaudineau Y, Croquefer S, Jousse S, Renaudineau E et al (2006) Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum 54:2523–2532CrossRefPubMed Renaudineau Y, Croquefer S, Jousse S, Renaudineau E et al (2006) Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum 54:2523–2532CrossRefPubMed
19.
Zurück zum Zitat Austin HA 3rd, Muenz LR, Joyce KM et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391CrossRefPubMed Austin HA 3rd, Muenz LR, Joyce KM et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391CrossRefPubMed
20.
Zurück zum Zitat Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic PD (1989) Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 18:189–197CrossRefPubMed Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic PD (1989) Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 18:189–197CrossRefPubMed
21.
Zurück zum Zitat Blum A, Rubinow A, Galun E (1991) Predominance of renal involvement in male patients with systemic lupus erythematosus. Clin Exp Rheumatol 9:206–207PubMed Blum A, Rubinow A, Galun E (1991) Predominance of renal involvement in male patients with systemic lupus erythematosus. Clin Exp Rheumatol 9:206–207PubMed
22.
Zurück zum Zitat Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML (1998) The clinical features and prognosis of male lupus in Taiwan. Lupus 7:462–468CrossRefPubMed Chang DM, Chang CC, Kuo SY, Chu SJ, Chang ML (1998) The clinical features and prognosis of male lupus in Taiwan. Lupus 7:462–468CrossRefPubMed
23.
Zurück zum Zitat Molina JF, Drenkard C, Molina J et al (1996) Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) 75(12):4–130 Molina JF, Drenkard C, Molina J et al (1996) Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore) 75(12):4–130
24.
Zurück zum Zitat Mok CC, Ho CT, Chan KW, Lau CS, Wong RW (2002) Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum 46:1003–1010CrossRefPubMed Mok CC, Ho CT, Chan KW, Lau CS, Wong RW (2002) Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum 46:1003–1010CrossRefPubMed
25.
Zurück zum Zitat Yoo CW, Kim MK, Lee HS (2000) Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy. Nephrol Dial Transplant 15:1604–1608CrossRefPubMed Yoo CW, Kim MK, Lee HS (2000) Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy. Nephrol Dial Transplant 15:1604–1608CrossRefPubMed
Metadaten
Titel
Male gender results in more severe lupus nephritis
verfasst von
Jozélio Freire de Carvalho
Ana Patrícia do Nascimento
Leonardo A. Testagrossa
Rui Toledo Barros
Eloísa Bonfá
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 10/2010
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1151-9

Weitere Artikel der Ausgabe 10/2010

Rheumatology International 10/2010 Zur Ausgabe

Letter to the Editor

Imaging mystery

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.